This insider cluster is too small to warrant a trading signal. Monitor for larger C-suite transactions or a material corporate event (e.g., earnings, pipeline update) that could provide context for any future insider activity.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Aug 5 $8.11entry
- T+1 · 3mo ago −9.25%α −9.09% · $7.36
- T+5 · 3mo ago +4.69%α +4.33% · $8.49
- T+20 · 3mo ago +5.80%α +6.40% · $8.58
- T+60 · 19d ago +32.55%α +32.61% · $10.75
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two non-C-suite insiders at Xeris Biopharma sold a combined $254K in open-market transactions over a 7-day window. The total value represents just 0.018% of the company's $1.4B market cap, making this a routine and immaterial cluster with no predictive signal.
Key Financial Metrics
Key Facts
- Two insiders (Beth Hecht and Kevin McCulloch, both 'See Remarks') sold shares on August 3, 2026.
- Total sale value: $253,793 (Hecht: $133,553; McCulloch: $120,240).
- Sales represent ~0.018% of Xeris's $1.4B market cap, well below the 0.1% materiality threshold.
- Both transactions were open-market sales; no 10b5-1 plan or regular pattern noted.
Financial Impact
Negligible, $254K in insider sales is less than 0.02% of market cap.
Risk Factors
- Insider sales at this trivial level carry no informational content; no bearish read-through.
- Larger insider sales or a cluster exceeding 0.5% of market cap would be a more meaningful signal.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-XERS-1785901908217 |
Track record
25 reports on XERS
4 of 4 bullish or bearish reports moved the stock their way by T+20. Best: +45.52% at T+60 after the Aug 6, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $15.86 Now $16.70 +5.30% settles Dec 8
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $15.20 Now $16.70 +9.87% settles Dec 7
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 4, 202612d ago 3 Neutral 2/10 Entry $13.08 Now $16.70 +27.68% settles Dec 4
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $10.35 Now $16.70 +61.35% settles Dec 2
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $10.17 Now $16.70 +64.21% settles Dec 1
- Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $10.71 Now $16.70 +55.93% settles Nov 30
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $9.77 to $16.52 Now $16.70 +70.93% ▲ +69.09% +70.36% vs SPY
- Oct 2, 20266w ago Insider Cluster Neutral 3/10 Entry $10.13 to $10.71 Now $16.70 +64.86% ▲ +5.73% +8.19% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers